Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Novartis (Miochol)

M&A STATUS
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

An inject-able miotic pharmaceutical drug. The asset is used during certain eye surgeries to constrict the pupil.

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • Global Eye Health Center
  • 1400 North Goodman Street
  • Rochester, NY 14609
  • United States

Novartis (Miochol) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Novartis (Miochol)‘s full profile, request access.

Request full access to PitchBook

Novartis (Miochol) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Novartis (Miochol)‘s full profile, request access.

Request full access to PitchBook